Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): a systematic review
Background: The World Health Organization characterized the Coronavirus disease 2019 (COVID-19) as a pandemic on March 11th. Many clinical trials on COVID-19 have been registered, and we aim to review the study characteristics and provide guidance for future trials to avoid duplicated effort. Method...
Main Authors: | Ming Yang, Ya-xi Shang, Zi-yu Tian, Min Xiong, Chun-li Lu, Yue Jiang, Yao Zhang, Ying-ying Zhang, Xin-yan Jin, Qiu-bai Jin, Ying Zhang, Merlin L. Willcox, Jian-ping Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Integrative Medicine Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213422020300585 |
Similar Items
-
Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov
by: Hanting Wu, et al.
Published: (2022-03-01) -
Clinical trials of stem cell-based therapies for pediatric diseases: a comprehensive analysis of trials registered on ClinicalTrials.gov and the ICTRP portal site
by: Yinwen Ji, et al.
Published: (2022-07-01) -
Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis
by: Lin-Lu Ma, et al.
Published: (2020-09-01) -
Information on blinding in registered records of clinical trials
by: Viergever Roderik F, et al.
Published: (2012-11-01) -
Trials that turn from retrospectively registered to prospectively registered: a cohort study of “retroactively prospective” clinical trial registration using history data
by: Martin Holst, et al.
Published: (2024-03-01)